Abstract
Contractile forces within the planar interface between T cell and antigen-presenting surface mechanically stimulate T cell receptors (TCR) in the mature immune synapses. However, the origin of mechanical stimulation during the initial, i.e., presynaptic, microvilli-based TCR activation in the course of immune surveillance remains unknown and new tools to help address this problem are needed. In this work, we develop nucleic acid nanoassembly (NAN)-based technology for functionalization of hydrogels using isothermal toehold-mediated reassociation of RNA/DNA heteroduplexes. Resulting platform allows for regulation with NAN linkers of 3D force momentum along the TCR mechanical axis, whereas hydrogels contribute to modulation of 2D shear modulus. By utilizing different lengths of NAN linkers conjugated to polyacrylamide gels of different shear moduli, we demonstrate an efficient capture of human T lymphocytes and tunable activation of TCR, as confirmed by T-cell spreading and pY foci.
Keywords: T-cell activation, nucleic acid nanotechnology, mechanosensing, T cell, TCR mechanosensing, Mechanobiology
Graphical Abstract
We enhance activation of primary human T cells by increasing sensitivity of TCR complex to the mechanical signals provided by biomimetic antigen. We achieve this effect by using nucleic acid nanoassemblies for tethering antigen to the presenting surface. Our results highlight the important role for nanoscale configuration of mechanical forces within the TCR-pMHC complex during antigen presentation.
INTRODUCTION
T cells play a central role in allergies1–3, autoimmune diseases4,5, infections6, and cancers7–11 orchestrating immune response with the molecular machinery consolidated around the mechanosensitive T-cell receptor (TCR)12–15. TCR activates formation of the immune synapse (IS) upon recognition of cognate peptide-loaded major histocompatibility complex (pMHC)15–18 on the surface of antigen-presenting cell (APC). Most studies of mechanosensitive TCR activation use a simplified model of the IS with the T cell-APC interactions are approximated to a 2D plane that features tangential actomyosin-driven mechanostimulatory tractions19–21, non-physiological levels of cell stimulation with cytokines (e.g., IL-2)22, and nominal contributions of non-actomyosin cytoskeleton subsystems23.
In the contractility-centered IS model, TCR activation requires prerequisite coalescence of solid state24 signalosomes25–27 that appear through F-actin microcluster-enriched foci28. These TCR foci initiate the antigen-induced signaling at the tips of nanoscale membranous protrusions, called microvilli, that are responsible for the initial T-cell-APC engagement29,30 during the IS development (Figure 1A–1) and later for signaling in the mature IS28,31. The TCR-pMHC complex receives mechanosensitive12,15,32 stimulation from the mature IS cytoskeletal centripetal forces, facilitated by non-muscle myosin 2A contractility20,33 and F-actin polymerization34 (Figure 1A–2,3). The same set of forces triggers downstream CasL, Zap70, and Nck-Lck signaling20,33 (Figure 1A–3) resulting in the activation of T cells.
However, TCR activation in the presynaptic phase happens through the glycocalyx coat between antigen-presenting surfaces29 or through the cell surface with invadosomes35, allowing for coalescence of antigen chemo- and mechanosensing that is necessary for the stimulation of T cells28,35–37. The F-actin microcluster forces are similar to focal 3D deformation forces of F-actin “comet tails”38 that generate derivative momentums39–42 and membrane deformations40,43–46 but not in-plane shear traction forces31,47–50. Moreover, the activation of TCR in microvilli happens in the presence of the actomyosin contractility inhibitor Blebbistatin51,52, thus suggesting that F-actin microclusters generate enough signals for TCR activation via the contractility-independent focal polymerization of actin.
We hypothesize that actomyosin contractility is less important during the initial microvilli-based TCR activation29,30,53. Instead, activation can be provided by the applied 3D force momentum of polymerizing actin (also “torque” or “TCR bending”) that is generated during microcluster deformation. The hypothesis of TCR activation by focal polymerization of 3D actin (e.g., by the “comet tail” F-actin microclusters) could explain the early stages of IS formation20,28,54, presynaptic TCR activation by antigen-decorated plastic beads47,49,50,55 and spatially constrained adhesions36,37 that do not support formation of the conventional planar IS. TCR activation by focal actin polymerization could also explain the extreme lymphocyte activation by complex 3D objects, such as carbon nanotubes, that induce much higher focal stresses within polymerizing 3D F-actin networks compared to the 2D shear modulus forces induced by the planar IS22,56–58.
No currently available methods - elastic biomimetic gels12, micro/nanopillars59–61, atomic force microscopy15, DNA25,62,63, and red blood cell probes36, can control the mechanical resistance at the level of individual foci. To test the role of 3D force momentum in force-dependent TCR activation12,28,31,64–67, we set out to develop a new approach for the functionalization of hydrogels with programmable nucleic acid nanoassemblies (NANs) that can be facilitated as linkers for regulated TCR binding and activation. The predictable and regulated base pairing, together with an expanding library of structural and interacting motifs and widely accessible computational tools allow for engineering nucleic acid nanodevices and nanoassemblies with controlled structural features, physicochemical properties, and biological profiles68–71. Using NANs, we decorate polyacrylamide gels (PAG, G’=50 kPa, shear modulus72) with OKT373, a mouse monoclonal antibody specific to the CD3ε subunit of the human TCR, that binds the CD3ε subunit and subsequently activates the TCR under the mechanical load15. Using OKT3-NANs-PAG surfaces, we demonstrate that NAN linkers of various lengths modulate the reaction of T cells to mechanical stresses transmitted via the PAG-NANs-OKT3-CD3ε axis. We also show that this system activates the TCR more effectively if both 3D force momentum and 2D shear force signals are present compared to the 2D shear force signals of conventional elastic substrates.
METHODS
All methods are detailed in Supporting Information.
Cell culture:
Human CD4+ T cells were isolated from commercially available whole human blood (STEMCELL Technologies Inc., USA) with EasySep Human CD4+ T Cell Isolation Kit (STEMCELL Technologies Inc., USA). Unless otherwise indicated, cells were cultured, activated and expanded in ImmunoCult-XF T Cell Expansion Medium (STEMCELL Technologies Inc., USA) with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc. commercial protocol.
Support fabrication:
Polyacrylamide gels (PAG) with micropatterned streptavidin lanes are manufactured as described elsewhere72,74. Briefly, a clean glass surface is microprinted with fluorescently labeled streptavidin-acrylamide conjugates via microcontact printing. The use of a hard PDMS (hPDMS75) composite stamp prevents patterns’ collapse onto the printed surface37,76. PAG premix with a desired shear modulus (G’)72 is polymerized in a “sandwich” manner. The polymerized “sandwich” is then hypotonically treated and the “intermediate” glass surface is gently peeled off the PAG layer, leaving the fluorescent pattern crosslinked to the PAG surface.
Preparation of NANs:
All sequences used in this project have been previously designed for the conditional activation of split functionalities intracellularly77,78 and their biotinylated analogs can be purchased (IDT). All sequences and protocols for heteroduplex formations are listed in the Supporting Information.
PAG conjugation with NAN-linkers:
The streptavidin-micropatterned PAG are incubated with various biotin-NAN conjugates for further OKT3 adsorption. Similarly, for more direct OKT3 crosslinking to the PAG surface via biotin-streptavidin or direct PAG crosslinking, the molecularly conjugated fluorescent OKT3 is printed on the glass surfaces, then cross-linked to the polymerizing PAG in a “sandwich” manner64,74.
Imaging:
Cell fixation, Alexa Fluor® 488 Anti-Phosphotyrosine, total myosin IIa and phalloidin-iFluor 488 or 647 labelling are performed according to the commercial protocol. Cell immunofluorescent labeling and confocal 3D imaging performed as described in the previous report37. Cell samples are mounted in 90% Glycerol (Sigma-Aldrich) in PBS (KDMedical) with 1 μg/mL Hoechst 33258 and 0.01% sodium azide preservative (Sigma-Aldrich) to prevent bacterial contamination and degradation of samples over time. The instant structured illumination microscopy (iSIM) is performed using a custom-build microscope (VisiTech).
RESULTS
Identification of 3D force momentum using different linkers for CD3ε-mediated TCR activation
Early antigen sensing and TCR activation at the nanoscale microvilli tips starts before the formation of the planar tensile IS. It indicates that traction force-independent non-contractile mechanisms provide the initial mechanical stimulation of TCR during the microvilli-based antigen surveillance and TCR engagement (Figure 2A–1,2,3). To test this hypothesis, we presented freshly isolated CD4+ T cells to the OKT3 dots. Both contractile (+DMSO, Figure 2A–4) and non-contractile (+Blebbistatin, 50 μM, Figure 2A–5) human T cells quickly engage multiple distant OKT3 dots via microvilli which is accompanied structural thickening of microvilli after 10 minutes. On T-cell microvilli tips, growing TCR microclusters can accumulate innate deformational stresses and 3D bending forces, that provide the mechanical stimulation for the TCR complex (Figure 2B–1) whereas mature immune synapse can also feature 2D tangential shear stresses driven by actomyosin contractility and lamellipodial polymerization-depolymerization turnover dynamics (Figure 2B–2). However, due to the spatial and time constraints, OKT3 dots do not support the formation of a mature tensile IS.
Since we target the CD3ε subunit of the TCR with an anti-CD3ε monoclonal antibody (OKT3, Figure 1B–1,2), the CD3ε subunit acts as the TCR complex’s mechanotransducer relay module that transmits the applied forces from the TCR-pMHC axis to the intracellular TCR signalosome79–81. We hypothesized that the mechanical stimuli applied to CD3ε via OKT3 binding would allow us to study the T-cell’s perception of mechanical stimuli under precisely controlled conditions (Figure 1B–2), e.g., bypassing highly variable TCR-pMHC interactions12,36,82.
Previous studies indicate that along with pulling-tension forces15,62, the TCR detects force momentum along each axis of the individual TCR-pMHC complexes14,47,55. Indeed, IS shear stresses induce the TCR drag that translates into secondary shear-induced force momentum (Figure 1B–3). However, a common simplification of the IS interface to a singular plane reduces the TCR-pMHC axis to the material point with shear stresses inducing only a symmetric reaction without the resulting momentum12,65. In this approximation, the force momentum can only be induced directly by the IS off-plane deformation forces. Conversely, a detailed T-cell-APC interaction model stipulates a shear-induced TCR-pMHC axis force momentum (Figure 1B–3) along with the momentum that is induced by the IS deformation forces52, effectively rendering force momentum as one of the most common mechanostimulatory signals during T-cell activation.
To test this hypothesis, we assess the effects of various linker lengths (Figure 3A) on the spreading of T cells along micrometer-wide OKT3 lanes. For “long” linkers, we utilize biotinylated OKT3 and streptavidin-PAG conjugates that consist of streptavidin (~5 nm), biotin-NMS (~1.4 nm), and OKT3 (~15 nm)83,84 accruing to the final length of ~22nm (Figure 3A–1). The “long” OKT3-biotin-streptavidin-acrylamide configuration results in poor T-cell spreading (Figure 3B,C, long linker), in agreement with previous reports65. Alternatively, “short” molecular linkers (~1 nm), made with OKT3 directly conjugated to PAG (Figure 3A–2), induce much stronger T-cell spreading (Figure 3B,C, short linker). The difference in T-cell responses is likely caused by either steric TCR-igniting exclusion of the CD45 molecule from the site of TCR-agonist cognate interaction27,85–88, or by the variation in the bending resistance of the OKT3-PAG axis, as both “long” and “short” linkers are attached to PAG of the same shear modulus and with comparable surface density of OKT3, as assessed by the relative brightness of all lanes in Figure 3C. Strikingly, when OKT3 antibodies are immobilized on the plasma-activated glass (Figure 3A–3), the strongest T-cell spreading (Figure 3B,C, Glass-OKT3) is observed, thus confirming the importance of linker length and origin of the support.
Designing a platform with tunable force resistance
To further assess the contribution of different antigen immobilization methods on force-dependent TCR activation, we utilize this newly developed platform with tunable force resistance. We take advantage of double-biotinylated dsDNAs as modular linkers between the streptavidin-micropatterned PAG and OKT3 antibodies. We compare three possible protocols of double-biotinylated DNA duplex formation: (i) one-step introduction of pre-made double-biotinylated dsDNAs, (ii) step-wise hybridization between single-stranded biotinylated DNAs, and (iii) step-wise toehold-mediated re-association of RNA/DNA heteroduplexes77 (Figure 4 and Figures S1–2).
Prior to PAG functionalization tests, we assess the relative kinetics of dsDNA linker formations using streptavidin-decorated quantum dots (QDs). Upon the formation of double-biotinylated duplexes using any of the assembly strategies, the crosslinking of QDs results in QD lattice formations89 which alter the electrophoretic mobility of the samples and present as aggregation when visualized via electrophoretic mobility shift assays. While the use of double-biotinylated dsDNAs has the fastest kinetics of QD lattice formation, its direct introduction to streptavidin-coated PAG passivates all available biotins (Figure S1D), thus preventing any further conjugation for streptavidin-OKT3. Among the other two protocols, the reassocication of RNA/DNA heteroduplexes results in a complete QD lattice formation after 30 minutes of incubation, while the ssDNA approach still shows some incomplete assemblies even after 2 hours of incubation at 37 °C. This difference can be explained by the potential formation of secondary structures within ssDNAs that delay their annealing to complementary strands, while this possibility is absent in the case of RNA/DNA heteroduplexes. Therefore, we establish the toehold-mediated reassociation of RNA/DNA heteroduplexes to be an optimal strategy for all future studies with OKT3-NAN-PAG systems. Importantly, the same strategy can be applied for longer RNA/DNA heteroduplexes with either continuous or segmented RNAs in their composition (Figure S2).
The protocol of isothermal reassociation of DNA/RNA heteroduplexes demonstrates best results (Figure 4B) and allows for a tighter control over the OKT3-NAN-PAG system by following four simple steps (Figure 4A): (i) conjugation of biotinylated RNA/DNA heteroduplexes to streptavidin-coated PAG surfaces (step 1), (ii) passivation of unoccupied streptavidin with free biotin (steps 2 and 3), (iii) introduction of the distal biotin group via cognate DNA/RNA heteroduplexes’ reassociation (steps 4 and 5), and (iv) conjugation of OKT3 antibodies (steps 6 and 7). Passivation of the unoccupied streptavidin with free biotin on the PAG surface prior to the introduction of the distal biotin group (steps 2 and 3) prevents its locking onto the PAG-streptavidin surface in the “pull handle” configuration (Figure S1D–1). We verify this notion by comparing the efficiencies of all protocols through measurements of the fluorescent OKT3-streptavidin adsorption onto microlanes (Figure S1). The results indicate a significant drop in [OKT3-streptavidin] - [biotin-dsDNA-biotin] - [streptavidin-PAG] formation when assembled via a single-step protocol, hence confirming a significant loss of accessible distal biotin due to its locking onto the streptavidin-PAG surfaces.
Cooperation of 3D Force Momentum and 2D Shear Force in the Activation of T cells
The demonstrated effect of the linker length on TCR activation (Figure 3) can result from sterically driven kinetic segregation (KS) between the TCR and CD45 receptors27,85–88. In the KS model, an elongated and rigid extracellular domain of the CD45 receptor (ECD-CD45) is sterically segregated from areas of tight contact between the T-cell and APC. The 13 nm-long axis of TCR-pMHC adhesion results in an intercellular gap clearance that sterically excludes 21 nm-long ECD-CD45. This spatial separation between receptor complexes modulates TCR activation86. However, the KS model has been largely unverified for early TCR activation90. To assess the potential contribution of KS, we evaluate the final clearance for all our experimentally tested linkers. In our systems, we bypass the TCR receptor subunit and directly target the 3 nm-long extracellular portion of the CD3ε subunit27 with the 15 nm-long OKT3 antibody, resulting in the minimal clearance of 18 nm (Figure 5A). The final steric clearances after the addition of NANs (39, 66 and 93 bp) and biotin-streptavidin linkers for OKT3 and PAG accrue to lengths that exceed that of ECD-CD45 (Figure 5A), confirming that TCR activation effects are independent from KS. Moreover, the strong agonistic effect of the anti-CD3ε OKT3 antibody activates TCR irrespectively to TCR-CD45 segregation91,92.
Considering the dsDNAs as elastically flexible rods93, the NANs’ lengths are inversely proportional to the mechanical bending resistance (Figure 1B). Therefore, we examine the effects of NAN length (by testing 39, 66, 81, and 93 bp linkers) and PAG shear modulus (by testing 2.3, 8.6, and 50 kPa PAGs) on T-cell adhesion and spreading along OKT3-NAN-PAG microlanes. We also compare NANs to polymer linkers (short and long, Figure 3) attached to the same shear moduli PAG. When 2.3 kPa PAG is used, the T-cell spreading is comparable between all types of linkers. For 50 kPa PAG support, the T-cell spreading is equally higher for “short” and dsDNA linkers when compared to “long” linkers. However, we identify that by keeping bearing PAG at a shear modulus of G’=8.6 kPa, the significant difference in T-cell responses as a function of the dsDNA length is clearly observed (Figure 5B,C). These results indicate that, despite the identical mechanical rigidity of gels and OKT3 density, T-cells develop significantly stronger responses (assessed by 1D spreading/early activation) on the microlanes decorated with 39 bp dsDNAs (Figure 5 B,C). For the same linker used in combination with different shear moduli PAGs, the spreading increases with a higher shear modulus. Thus, we conclude that along with in-plane shear stress resistance, TCR-antigen sensing is strongly modulated by the CD3ε-OKT3-NAN-PAG axis bending resistance to 3D force momentum.
We observe a strong modulation of T-cell adhesion and spreading on the PAG-NANs-OKT3 platforms with gel-to-cell surface clearance gaps that are well beyond the physical length (~21 nm) of the CD45 extracellular domain (Figure 5A)27,88. In our system, the narrowest T-cell-PAG surface clearance for PAG-NANs-OKT3 linkers is ~39 nm, where L(NAN 39 bp)>L(ECD-CD45), which supports efficient T-cell spreading (Figure 4B, Figure 5B,C). Moreover, 39 bp-long NAN linkers induce T-cell spreading on the soft G’=8.6 kPa PAG surfaces with a shear modulus value that does not induce T-cell spreading via the short OKT3-acryl linker (Figure 5C, 8.6 kPa, short linker). This is despite the fact that the latter linker-facilitated clearance is ~18 nm, which is shorter than the ~21 nm-long CD45 extracellular domain L(OKT3-acryl)<L(ECD-CD45), (Figure 5A). Instead, we observe a sharp decrease of T-cell spreading activity on the platform with the next available T-cell-PAG clearance width of ~48 nm (L(NAN 66 bp)>L(ECD-CD45), Figure 5B). Thus, the CD45-driven KS effect is not responsible for early TCR-driven T-cell adhesion and spreading, but rather the resistance to mechanical bending along the CD3ε-OKT3-dsDNA-PAG axis. One of the alternative mechanosensing models, known as “catch bond,” suggests that the energy of TCR-pMHC interactions increases with the applied force94 acting as a TCR-pMHC proofreading mechanical latch aiding to differentiate between stimulatory and non-stimulatory TCR-pMHC interactions95,96. However, the dynamics of this model is not always captured in non-cellular systems97, indicating that the proposed mechanism may be an effect of other cellular responses, and does not represent an intrinsic TCR-pMHC bonding property. In particular, 3D forces52 within the T cell immune synapse and our results indicate that the 2D tangential forces, which are responsible for sensing the shear modulus of the substrate, do not fully represent the mechanical configuration of all forces during the TCR mechanosensation.
Signal transduction through the TCR initiates a cascade of signaling events which induce the phosphorylation of CD3 tyrosine-based activation motifs which are not specifically required for late T-cell activation, but rather which contribute quantitatively to TCR signaling98. To assess the role of NANs in TCR signaling, we analyze the pY foci response (Figure 6) comparing the gels with OKT3 immobilized by the short linkers and the 39 bp dsDNAs (Figure 6A–4). Immobilization of antibodies with short linkers provides up to 40x more OKT3 on the surface compared to dsDNAs (Figure 6A–1, lanes 1 and 4, lanes 2 and 5). The surface density of OKT3 translates into increased pY foci responses, up to 2x, both for gels of 8.6 kPa and 50 kPa shear moduli (Figure 6A–2, lanes 1 and 4, lanes 2 and 5; Figure 6B, lanes 1 and 4, lanes 2 and 5). However, OKT3 lanes, G’ of 50 kPa, with a normalized density of OKT3 (diluted, short linker), provide a negligible pY foci response (Figure 6A–2, lane 3; Figure 6B, lane 3) and no cell spreading (Figure 6A–3, lane 3) compared to 39 bp dsDNA-immobilized OKT3 lanes of similar density and shear modulus (Figure 6A–2, lane 5; Figure 6A–3, lane 5; Figure 6B, lane 5). In addition, the 39 bp dsDNA-immobilized OKT3 lanes show an increase in pY response in T cells following the increase of gel shear force modulus from 8.6 kPa gel to 50 kPa (Figure 6A–2, lanes 4 and 5; Figure 6B, lanes 4 and 5).
DISCUSSION
Our results show that programmable hydrogel coating, i.e., NANs, is suitable for the ligand attachment and controlling its mechanical resistance. Using NANs, we show the complementary role of 3D force momentum and in-plane 2D shear forces in mechanical lymphocyte stimulation. We conclude that NANs will be useful for studying the complex signalosome assembled around the microvilli TCRs.
From potential biomedical perspectives, NANs would be (i) pyrogen-free99, immunoquiescent100,101, and safe for extracellular use with human immune cells70; (ii) tunable for force resistance actuation through reconfiguration in isothermal conditions77,78,102–104; and (iii) recomposable with cognate NANs with similar physicochemical properties, reassociation rates, and biological activities105. NANs can be designed to vary in size100, stiffness93, functional composition106, and encode thermodynamically-driven isothermal interactions that promote conformational changes, which, in turn, could alter the experimental outcomes for mechanosensory and functional properties of the initial NANs100.
We envision this modular platform to become instrumental for exploring the behaviour of human immune cells ex vivo, thus expanding the possibilities of basic research and immunotherapies. In basic research, NAN-PAG conjugates could be used to study homing receptors and molecular machinery consolidated around the mechanosensitive TCR to elucidate co-stimulatory and co-inhibitory signals that regulate antigen search and TCR engagement strategies. In translational studies, NANs could be used for optimizing CD8+ T cell activation, e.g., during conditioning of CAR T constructs in non-clinical settings.
Supplementary Material
ACKNOWLEDGMENTS
We thank Nikolay Dokholyan for the critical feedback and fruitful discussion, Christian Combs and Daniela Malide (NHLBI Light Microscopy Core) for the imaging support.
Financial support information: A.S.Z. was supported by the FDA Intramural Research and NHLBI Division of Intramural Research (HL006209). Also, research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers R01GM120487 and R35GM139587 (to K.A.A). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. E.D.T. is supported by the Department of Pharmacology startup funds from Penn State College of Medicine.
Footnotes
All authors declare no financial conflict of interest associated with this study.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
REFERENCES:
- (1).Akdis CA; Akdis M Mechanisms and Treatment of Allergic Disease in the Big Picture of Regulatory T Cells. J. Allergy Clin. Immunol 2009, 123 (4), 735–746; quiz 747–748. 10.1016/j.jaci.2009.02.030. [DOI] [PubMed] [Google Scholar]
- (2).Skuljec J; Chmielewski M; Happle C; Habener A; Busse M; Abken H; Hansen G Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma. Front. Immunol 2017, 8, 1125. 10.3389/fimmu.2017.01125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Woodfolk JA T-Cell Responses to Allergens. J. Allergy Clin. Immunol 2007, 119 (2), 280–294; quiz 295–296. 10.1016/j.jaci.2006.11.008. [DOI] [PubMed] [Google Scholar]
- (4).Winblad B; Graf A; Riviere M-E; Andreasen N; Ryan JM Active Immunotherapy Options for Alzheimer’s Disease. Alzheimers. Res. Ther 2014, 6 (1), 7. 10.1186/alzrt237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Brody DL; Holtzman DM Active and Passive Immunotherapy for Neurodegenerative Disorders. Annu. Rev. Neurosci 2008, 31, 175–193. 10.1146/annurev.neuro.31.060407.125529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).Manohar A; Ahuja J; Crane JK Immunotherapy for Infectious Diseases: Past, Present, and Future. Immunol. Invest 2015, 44 (8), 731–737. 10.3109/08820139.2015.1093914. [DOI] [PubMed] [Google Scholar]
- (7).Milone MC; Fish JD; Carpenito C; Carroll RG; Binder GK; Teachey D; Samanta M; Lakhal M; Gloss B; Danet-Desnoyers G; Campana D; Riley JL; Grupp SA; June CH Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy in Vivo. Mol. Ther 2009, 17 (8), 1453–1464. 10.1038/mt.2009.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Kalos M; Levine BL; Porter DL; Katz S; Grupp SA; Bagg A; June CH T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia. Sci. Transl. Med 2011, 3 (95), 95ra73. 10.1126/scitranslmed.3002842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Porter DL; Hwang W-T; Frey NV; Lacey SF; Shaw PA; Loren AW; Bagg A; Marcucci KT; Shen A; Gonzalez V; Ambrose D; Grupp SA; Chew A; Zheng Z; Milone MC; Levine BL; Melenhorst JJ; June CH Chimeric Antigen Receptor T Cells Persist and Induce Sustained Remissions in Relapsed Refractory Chronic Lymphocytic Leukemia. Sci. Transl. Med 2015, 7 (303), 303ra139. 10.1126/scitranslmed.aac5415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Maude SL; Frey N; Shaw PA; Aplenc R; Barrett DM; Bunin NJ; Chew A; Gonzalez VE; Zheng Z; Lacey SF; Mahnke YD; Melenhorst JJ; Rheingold SR; Shen A; Teachey DT; Levine BL; June CH; Porter DL; Grupp SA Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. N. Engl. J. Med 2014, 371 (16), 1507–1517. 10.1056/NEJMoa1407222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Porter DL; Levine BL; Kalos M; Bagg A; June CH Chimeric Antigen Receptor–modified T Cells in Chronic Lymphoid Leukemia. N. Engl. J. Med 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Judokusumo E; Tabdanov E; Kumari S; Dustin ML; Kam LC Mechanosensing in T Lymphocyte Activation. Biophys. J 2012, 102 (2), L5–L7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).Li Y-C; Chen B-M; Wu P-C; Cheng T-L; Kao L-S; Tao M-H; Lieber A; Roffler SR Cutting Edge: Mechanical Forces Acting on T Cells Immobilized via the TCR Complex Can Trigger TCR Signaling. J. Immunol 2010, 184 (11), 5959–5963. 10.4049/jimmunol.0900775. [DOI] [PubMed] [Google Scholar]
- (14).Rossy J; Laufer JM; Legler DF Role of Mechanotransduction and Tension in T Cell Function. Front. Immunol 2018, 9, 2638. 10.3389/fimmu.2018.02638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).Hu KH; Butte MJ T Cell Activation Requires Force Generation. J. Cell Biol 2016, 213 (5), 535–542. 10.1083/jcb.201511053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Rudolph MG; Wilson IA The Specificity of TCR/pMHC Interaction. Curr. Opin. Immunol 2002, 14 (1), 52–65. 10.1016/s0952-7915(01)00298-9. [DOI] [PubMed] [Google Scholar]
- (17).Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC Structure of the Complex between Human T-Cell Receptor, Viral Peptide and HLA-A2. Nature 1996, 384 (6605), 134–141. 10.1038/384134a0. [DOI] [PubMed] [Google Scholar]
- (18).Garcia KC; Degano M; Stanfield RL; Brunmark A; Jackson MR; Peterson PA; Teyton L; Wilson IA An Alphabeta T Cell Receptor Structure at 2.5 A and Its Orientation in the TCR-MHC Complex. Science 1996, 274 (5285), 209–219. 10.1126/science.274.5285.209. [DOI] [PubMed] [Google Scholar]
- (19).Hong J; Murugesan S; Betzig E; Hammer JA Contractile Actomyosin Arcs Promote the Activation of Primary Mouse T Cells in a Ligand-Dependent Manner. PLoS One 2017, 12 (8), e0183174. 10.1371/journal.pone.0183174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Yu Y; Fay NC; Smoligovets AA; Wu H-J; Groves JT Myosin IIA Modulates T Cell Receptor Transport and CasL Phosphorylation during Early Immunological Synapse Formation. PLoS One 2012, 7 (2), e30704. 10.1371/journal.pone.0030704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Yu Y; Smoligovets AA; Groves JT Modulation of T Cell Signaling by the Actin Cytoskeleton. J. Cell Sci 2013, 126 (Pt 5), 1049–1058. 10.1242/jcs.098210. [DOI] [PubMed] [Google Scholar]
- (22).Fadel TR; Sharp FA; Vudattu N; Ragheb R; Garyu J; Kim D; Hong E; Li N; Haller GL; Pfefferle LD; Justesen S; Herold KC; Fahmy TM A Carbon Nanotube-Polymer Composite for T-Cell Therapy. Nat. Nanotechnol 2014, 9 (8), 639–647. 10.1038/nnano.2014.154. [DOI] [PubMed] [Google Scholar]
- (23).Blumenthal D; Burkhardt JK Multiple Actin Networks Coordinate Mechanotransduction at the Immunological Synapse. J. Cell Biol 2020, 219 (2). 10.1083/jcb.201911058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (24).Su X; Ditlev JA; Hui E; Xing W; Banjade S; Okrut J; King DS; Taunton J; Rosen MK; Vale RD Phase Separation of Signaling Molecules Promotes T Cell Receptor Signal Transduction. Science 2016, 352 (6285), 595–599. 10.1126/science.aad9964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Taylor MJ; Husain K; Gartner ZJ; Mayor S; Vale RD A DNA-Based T Cell Receptor Reveals a Role for Receptor Clustering in Ligand Discrimination. Cell 2017, 169 (1), 108–119.e20. 10.1016/j.cell.2017.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (26).Manz BN; Jackson BL; Petit RS; Dustin ML; Groves J T-Cell Triggering Thresholds Are Modulated by the Number of Antigen within Individual T-Cell Receptor Clusters. Proc. Natl. Acad. Sci. U. S. A 2011, 108 (22), 9089–9094. 10.1073/pnas.1018771108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (27).Cai H; Muller J; Depoil D; Mayya V; Sheetz MP; Dustin ML; Wind SJ Full Control of Ligand Positioning Reveals Spatial Thresholds for T Cell Receptor Triggering. Nat. Nanotechnol 2018, 13 (7), 610–617. 10.1038/s41565-018-0113-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Kumari S; Depoil D; Martinelli R; Judokusumo E; Carmona G; Gertler FB; Kam LC; Carman CV; Burkhardt JK; Irvine DJ; Dustin ML Actin Foci Facilitate Activation of the Phospholipase C-γ in Primary T Lymphocytes via the WASP Pathway. Elife 2015, 4. 10.7554/eLife.04953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Jung Y; Riven I; Feigelson SW; Kartvelishvily E; Tohya K; Miyasaka M; Alon R; Haran G Three-Dimensional Localization of T-Cell Receptors in Relation to Microvilli Using a Combination of Superresolution Microscopies. Proc. Natl. Acad. Sci. U. S. A 2016, 113 (40), E5916–E5924. 10.1073/pnas.1605399113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (30).Cai E; Marchuk K; Beemiller P; Beppler C; Rubashkin MG; Weaver VM; Gérard A; Liu T-L; Chen B-C; Betzig E; Bartumeus F; Krummel MF Visualizing Dynamic Microvillar Search and Stabilization during Ligand Detection by T Cells. Science 2017, 356 (6338). 10.1126/science.aal3118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (31).Kumari S; Mak M; Poh Y-C; Tohme M; Watson N; Melo M; Janssen E; Dustin M; Geha R; Irvine DJ Cytoskeletal Tension Actively Sustains the Migratory T-Cell Synaptic Contact. EMBO J. 2020, e102783. 10.15252/embj.2019102783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).Basu R; Whitlock BM; Husson J; Le Floc’h A; Jin W; Oyler-Yaniv A; Dotiwala F; Giannone G; Hivroz C; Biais N; Lieberman J; Kam LC; Huse M Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing. Cell 2016, 165 (1), 100–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (33).Kumari S; Vardhana S; Cammer M; Curado S; Santos L; Sheetz MP; Dustin ML T Lymphocyte Myosin IIA Is Required for Maturation of the Immunological Synapse. Front. Immunol 2012, 3, 230. 10.3389/fimmu.2012.00230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (34).Hammer JA 3rd; Burkhardt JK Controversy and Consensus Regarding Myosin II Function at the Immunological Synapse. Curr. Opin. Immunol 2013, 25 (3), 300–306. 10.1016/j.coi.2013.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (35).Sage PT; Varghese LM; Martinelli R; Sciuto TE; Kamei M; Dvorak AM; Springer TA; Sharpe AH; Carman CV Antigen Recognition Is Facilitated by Invadosome-like Protrusions Formed by Memory/effector T Cells. J. Immunol 2012, 188 (8), 3686–3699. 10.4049/jimmunol.1102594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (36).Husson J; Chemin K; Bohineust A; Hivroz C; Henry N Force Generation upon T Cell Receptor Engagement. PLoS One 2011, 6 (5), e19680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (37).Tabdanov E; Gondarenko S; Kumari S; Liapis A; Dustin ML; Sheetz MP; Kam LC; Iskratsch T Micropatterning of TCR and LFA-1 Ligands Reveals Complementary Effects on Cytoskeleton Mechanics in T Cells. Integr. Biol 2015, 7 (10), 1272–1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (38).Ditlev JA; Michalski PJ; Huber G; Rivera GM; Mohler WA; Loew LM; Mayer BJ Stoichiometry of Nck-Dependent Actin Polymerization in Living Cells. J. Cell Biol 2012, 197 (5), 643–658. 10.1083/jcb.201111113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (39).Boukellal H; Campás O; Joanny J-F; Prost J; Sykes C Soft Listeria: Actin-Based Propulsion of Liquid Drops. Phys. Rev. E Stat. Nonlin. Soft Matter Phys 2004, 69 (6 Pt 1), 061906. 10.1103/PhysRevE.69.061906. [DOI] [PubMed] [Google Scholar]
- (40).Fehrenbacher K; Huckaba T; Yang H-C; Boldogh I; Pon L Actin Comet Tails, Endosomes and Endosymbionts. J. Exp. Biol 2003, 206 (Pt 12), 1977–1984. 10.1242/jeb.00240. [DOI] [PubMed] [Google Scholar]
- (41).Giardini PA; Fletcher DA; Theriot JA Compression Forces Generated by Actin Comet Tails on Lipid Vesicles. Proc. Natl. Acad. Sci. U. S. A 2003, 100 (11), 6493–6498. 10.1073/pnas.1031670100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (42).Paluch E; van der Gucht J; Joanny J-F; Sykes C Deformations in Actin Comets from Rocketing Beads. Biophys. J 2006, 91 (8), 3113–3122. 10.1529/biophysj.106.088054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (43).Collins A; Warrington A; Taylor KA; Svitkina T Structural Organization of the Actin Cytoskeleton at Sites of Clathrin-Mediated Endocytosis. Curr. Biol 2011, 21 (14), 1167–1175. 10.1016/j.cub.2011.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (44).Kaksonen M; Sun Y; Drubin DG A Pathway for Association of Receptors, Adaptors, and Actin during Endocytic Internalization. Cell 2003, 115 (4), 475–487. 10.1016/s0092-8674(03)00883-3. [DOI] [PubMed] [Google Scholar]
- (45).Smythe E; Ayscough KR Actin Regulation in Endocytosis. J. Cell Sci 2006, 119 (Pt 22), 4589–4598. 10.1242/jcs.03247. [DOI] [PubMed] [Google Scholar]
- (46).Picco A; Kukulski W; Manenschijn HE; Specht T; Briggs JAG; Kaksonen M The Contributions of the Actin Machinery to Endocytic Membrane Bending and Vesicle Formation. Mol. Biol. Cell 2018, 29 (11), 1346–1358. 10.1091/mbc.E17-11-0688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (47).Kim ST; Shin Y; Brazin K; Mallis RJ; Sun Z-YJ; Wagner G; Lang MJ; Reinherz EL TCR Mechanobiology: Torques and Tunable Structures Linked to Early T Cell Signaling. Front. Immunol 2012, 3, 76. 10.3389/fimmu.2012.00076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (48).Kim ST; Takeuchi K; Sun Z-YJ; Touma M; Castro CE; Fahmy A; Lang MJ; Wagner G; Reinherz EL αβ T Cell Receptor Is an Anisotropic Mechanosensor. J. Biol. Chem 2009, 6284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (49).Feng Y; Brazin KN; Kobayashi E; Mallis RJ; Reinherz EL; Lang MJ Mechanosensing Drives Acuity of αβ T-Cell Recognition. Proc. Natl. Acad. Sci. U. S. A 2017, 114 (39), E8204–E8213. 10.1073/pnas.1703559114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (50).James JR Using the Force to Find the Peptides You’re Looking for. Proc. Natl. Acad. Sci. U. S. A 2017, 114 (39), 10303–10305. 10.1073/pnas.1713970114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (51).Tabdanov E; Gondarenko S; Kumari S; Liapis A; Dustin ML; Sheetz MP; Kam LC; Iskratsch T Micropatterning of TCR and LFA-1 Ligands Reveals Complementary Effects on Cytoskeleton Mechanics in T Cells. Integr. Biol 2015, 7 (10), 1272–1284. 10.1039/c5ib00032g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (52).Husson J; Chemin K; Bohineust A; Hivroz C; Henry N Force Generation upon T Cell Receptor Engagement. PLoS One 2011, 6 (5), e19680. 10.1371/journal.pone.0019680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (53).Kim H-R; Mun Y; Lee K-S; Park Y-J; Park J-S; Park J-H; Jeon B-N; Kim C-H; Jun Y; Hyun Y-M; Kim M; Lee S-M; Park C-S; Im S-H; Jun C-D T Cell Microvilli Constitute Immunological Synaptosomes That Carry Messages to Antigen-Presenting Cells. Nat. Commun 2018, 9 (1), 3630. 10.1038/s41467-018-06090-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (54).Ilani T; Vasiliver-Shamis G; Vardhana S; Bretscher A; Dustin MLT Cell Antigen Receptor Signaling and Immunological Synapse Stability Require Myosin IIA. Nat. Immunol 2009, 10 (5), 531–539. 10.1038/ni.1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (55).Kim ST; Takeuchi K; Sun Z-YJ; Touma M; Castro CE; Fahmy A; Lang MJ; Wagner G; Reinherz EL The αβ T Cell Receptor Is an Anisotropic Mechanosensor. J. Biol. Chem 2009, 284 (45), 31028–31037. 10.1074/jbc.M109.052712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (56).Cheung AS; Zhang DKY; Koshy ST; Mooney DJ Scaffolds That Mimic Antigen-Presenting Cells Enable Ex Vivo Expansion of Primary T Cells. Nat. Biotechnol 2018, 36 (2), 160–169. 10.1038/nbt.4047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (57).Tang L; Zheng Y; Melo MB; Mabardi L; Castaño AP; Xie Y-Q; Li N; Kudchodkar SB; Wong HC; Jeng EK; Maus MV; Irvine DJ Enhancing T Cell Therapy through TCR-Signaling-Responsive Nanoparticle Drug Delivery. Nat. Biotechnol 2018, 36 (8), 707–716. 10.1038/nbt.4181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (58).Irvine DJ; Dane EL Enhancing Cancer Immunotherapy with Nanomedicine. Nat. Rev. Immunol 2020. 10.1038/s41577-019-0269-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (59).Tamzalit F; Wang MS; Jin W; Tello-Lafoz M; Boyko V; Heddleston JM; Black CT; Kam LC; Huse M Interfacial Actin Protrusions Mechanically Enhance Killing by Cytotoxic T Cells. Sci Immunol 2019, 4 (33). 10.1126/sciimmunol.aav5445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (60).Bashour KT; Gondarenko A; Chen H; Shen K; Liu X; Huse M; Hone JC; Kam LC CD28 and CD3 Have Complementary Roles in T-Cell Traction Forces. Proc. Natl. Acad. Sci. U. S. A 2014, 111 (6), 2241–2246. 10.1073/pnas.1315606111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (61).Bashour KT; Tsai J; Shen K; Lee J-H; Sun E; Milone MC; Dustin ML; Kam LC Cross Talk between CD3 and CD28 Is Spatially Modulated by Protein Lateral Mobility. Mol. Cell. Biol 2014, 34 (6), 955–964. 10.1128/MCB.00842-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (62).Liu Y; Blanchfield L; Ma VP-Y; Andargachew R; Galior K; Liu Z; Evavold B; Salaita K DNA-Based Nanoparticle Tension Sensors Reveal That T-Cell Receptors Transmit Defined pN Forces to Their Antigens for Enhanced Fidelity. Proc. Natl. Acad. Sci. U. S. A 2016, 113 (20), 5610–5615. 10.1073/pnas.1600163113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (63).Blanchard AT; Salaita K Emerging Uses of DNA Mechanical Devices. Science 2019, 365 (6458), 1080–1081. 10.1126/science.aax3343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (64).Tabdanov ED; Puram V; Zhovmer A; Provenzano PP Microtubule-Actomyosin Mechanical Cooperation during Contact Guidance Sensing. Cell Rep. 2018, 25 (2), 328–338.e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (65).Saitakis M; Dogniaux S; Goudot C; Bufi N; Asnacios S; Maurin M; Randriamampita C; Asnacios A; Hivroz C Different TCR-Induced T Lymphocyte Responses Are Potentiated by Stiffness with Variable Sensitivity. Elife 2017, 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (66).Wahl A; Dinet C; Dillard P; Nassereddine A; Puech P-H; Limozin L; Sengupta K Biphasic Mechanosensitivity of T Cell Receptor-Mediated Spreading of Lymphocytes. Proc. Natl. Acad. Sci. U. S. A 2019, 116 (13), 5908–5913. 10.1073/pnas.1811516116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (67).Santos LC; Blair DA; Kumari S; Cammer M; Iskratsch T; Herbin O; Alexandropoulos K; Dustin ML; Sheetz MP Actin Polymerization-Dependent Activation of Cas-L Promotes Immunological Synapse Stability. Immunol. Cell Biol 2016, 94 (10), 981–993. 10.1038/icb.2016.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (68).Afonin KA; Dobrovolskaia MA; Church G; Bathe M Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology. ACS Nano 2020, 14 (8), 9221–9227. 10.1021/acsnano.0c04753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (69).Johnson MB; Halman JR; Miller DK; Cooper JS; Khisamutdinov EF; Marriott I; Afonin KA The Immunorecognition, Subcellular Compartmentalization, and Physicochemical Properties of Nucleic Acid Nanoparticles Can Be Controlled by Composition Modification. Nucleic Acids Res. 2020, 48 (20), 11785–11798. 10.1093/nar/gkaa908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (70).Dobrovolskaia MA; Afonin KA Use of Human Peripheral Blood Mononuclear Cells to Define Immunological Properties of Nucleic Acid Nanoparticles. Nat. Protoc 2020, 15 (11), 3678–3698. 10.1038/s41596-020-0393-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (71).Johnson MB; Chandler M; Afonin KA Nucleic Acid Nanoparticles (NANPs) as Molecular Tools to Direct Desirable and Avoid Undesirable Immunological Effects. Adv. Drug Deliv. Rev 2021, 173, 427–438. 10.1016/j.addr.2021.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (72).Plotnikov SV; Sabass B; Schwarz US; Waterman CM High-Resolution Traction Force Microscopy. Methods Cell Biol 2014, 123, 367–394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (73).Norman DJ Mechanisms of Action and Overview of OKT3. Ther. Drug Monit 1995, 17 (6), 615–620. 10.1097/00007691-199512000-00012. [DOI] [PubMed] [Google Scholar]
- (74).Tabdanov ED; Puram VV; Win Z; Alamgir A; Alford PW; Provenzano PP Bimodal Sensing of Guidance Cues in Mechanically Distinct Microenvironments. Nat. Commun 2018, 9 (1), 4891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (75).Odom TW; Love JC; Wolfe DB; Paul KE; Whitesides GM Improved Pattern Transfer in Soft Lithography Using Composite Stamps. Langmuir 2002, 18 (13), 5314–5320. [Google Scholar]
- (76).Shen K; Thomas VK; Dustin ML; Kam LC Micropatterning of Costimulatory Ligands Enhances CD4+ T Cell Function. Proc. Natl. Acad. Sci. U. S. A 2008, 105 (22), 7791–7796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (77).Afonin KA; Viard M; Martins AN; Lockett SJ; Maciag AE; Freed EO; Heldman E; Jaeger L; Blumenthal R; Shapiro BA Activation of Different Split Functionalities on Re-Association of RNA-DNA Hybrids. Nat. Nanotechnol 2013, 8 (4), 296–304. 10.1038/nnano.2013.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (78).Afonin KA; Desai R; Viard M; Kireeva ML; Bindewald E; Case CL; Maciag AE; Kasprzak WK; Kim T; Sappe A; Stepler M; Kewalramani VN; Kashlev M; Blumenthal R; Shapiro BA Co-Transcriptional Production of RNA-DNA Hybrids for Simultaneous Release of Multiple Split Functionalities. Nucleic Acids Res. 2014, 42 (3), 2085–2097. 10.1093/nar/gkt1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (79).Brazin KN; Mallis RJ; Boeszoermenyi A; Feng Y; Yoshizawa A; Reche PA; Kaur P; Bi K; Hussey RE; Duke-Cohan JS; Song L; Wagner G; Arthanari H; Lang MJ; Reinherz EL The T Cell Antigen Receptor α Transmembrane Domain Coordinates Triggering through Regulation of Bilayer Immersion and CD3 Subunit Associations. Immunity 2018, 49 (5), 829–841.e6. 10.1016/j.immuni.2018.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (80).Brazin KN; Mallis RJ; Das DK; Feng Y; Hwang W; Wang J-H; Wagner G; Lang MJ; Reinherz EL Structural Features of the αβTCR Mechanotransduction Apparatus That Promote pMHC Discrimination. Front. Immunol 2015, 6, 441. 10.3389/fimmu.2015.00441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (81).Ge C The Impact of TCR-CD3 and TCR-pMHC-CD8 Interaction on T Cell Activation. 2017.
- (82).Sawicka A; Babataheri A; Dogniaux S; Barakat AI; Gonzalez-Rodriguez D; Hivroz C; Husson J Micropipette Force Probe to Quantify Single-Cell Force Generation: Application to T-Cell Activation. Mol. Biol. Cell 2017, 28 (23), 3229–3239. 10.1091/mbc.E17-06-0385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (83).Klein JS; Gnanapragasam PNP; Galimidi RP; Foglesong CP; West AP Jr; Bjorkman PJ Examination of the Contributions of Size and Avidity to the Neutralization Mechanisms of the Anti-HIV Antibodies b12 and 4E10. Proc. Natl. Acad. Sci. U. S. A 2009, 106 (18), 7385–7390. 10.1073/pnas.0811427106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (84).Klein JS; Bjorkman PJ Few and Far between: How HIV May Be Evading Antibody Avidity. PLoS Pathog. 2010, 6 (5), e1000908. 10.1371/journal.ppat.1000908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (85).Varma R; Campi G; Yokosuka T; Saito T; Dustin ML T Cell Receptor-Proximal Signals Are Sustained in Peripheral Microclusters and Terminated in the Central Supramolecular Activation Cluster. Immunity 2006, 25 (1), 117–127. 10.1016/j.immuni.2006.04.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (86).Davis SJ; van der Merwe PA The Kinetic-Segregation Model: TCR Triggering and beyond. Nat. Immunol 2006, 7 (8), 803–809. 10.1038/ni1369. [DOI] [PubMed] [Google Scholar]
- (87).Allard JF; Dushek O; Coombs D; van der Merwe PA Mechanical Modulation of Receptor-Ligand Interactions at Cell-Cell Interfaces. Biophys. J 2012, 102 (6), 1265–1273. 10.1016/j.bpj.2012.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (88).Chang VT; Fernandes RA; Ganzinger KA; Lee SF; Siebold C; McColl J; Jönsson P; Palayret M; Harlos K; Coles CH; Jones EY; Lui Y; Huang E; Gilbert RJC; Klenerman D; Aricescu AR; Davis SJ Initiation of T Cell Signaling by CD45 Segregation at “Close Contacts.” Nat. Immunol 2016, 17 (5), 574–582. 10.1038/ni.3392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (89).Roark B; Tan JA; Ivanina A; Chandler M; Castaneda J; Kim HS; Jawahar S; Viard M; Talic S; Wustholz KL; Yingling YG; Jones M; Afonin KA Fluorescence Blinking as an Output Signal for Biosensing. ACS Sens 2016, 1 (11), 1295–1300. 10.1021/acssensors.6b00352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (90).Tan YX; Zikherman J; Weiss A Novel Tools to Dissect the Dynamic Regulation of TCR Signaling by the Kinase Csk and the Phosphatase CD45. Cold Spring Harb. Symp. Quant. Biol 2013, 78, 131–139. 10.1101/sqb.2013.78.020347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (91).Al-Aghbar MA; Chu Y-S; Chen B-M; Roffler SR High-Affinity Ligands Can Trigger T Cell Receptor Signaling Without CD45 Segregation. Front. Immunol 2018, 9, 713. 10.3389/fimmu.2018.00713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (92).Courtney AH; Shvets AA; Lu W; Griffante G; Mollenauer M; Horkova V; Lo W-L; Yu S; Stepanek O; Chakraborty AK; Weiss A CD45 Functions as a Signaling Gatekeeper in T Cells. Sci. Signal 2019, 12 (604). 10.1126/scisignal.aaw8151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (93).Kebbekus P; Draper DE; Hagerman P Persistence Length of RNA. Biochemistry 1995, 34 (13), 4354–4357. 10.1021/bi00013a026. [DOI] [PubMed] [Google Scholar]
- (94).Liu B; Chen W; Evavold BD; Zhu C Accumulation of Dynamic Catch Bonds between TCR and Agonist Peptide-MHC Triggers T Cell Signaling. Cell 2014, 157 (2), 357–368. 10.1016/j.cell.2014.02.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (95).Das DK; Feng Y; Mallis RJ; Li X; Keskin DB; Hussey RE; Brady SK; Wang J-H; Wagner G; Reinherz EL; Lang MJ Force-Dependent Transition in the T-Cell Receptor β-Subunit Allosterically Regulates Peptide Discrimination and pMHC Bond Lifetime. Proc. Natl. Acad. Sci. U. S. A 2015, 112 (5), 1517–1522. 10.1073/pnas.1424829112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (96).Sibener LV; Fernandes RA; Kolawole EM; Carbone CB; Liu F; McAffee D; Birnbaum ME; Yang X; Su LF; Yu W; Dong S; Gee MH; Jude KM; Davis MM; Groves JT; Goddard WA 3rd; Heath JR; Evavold BD; Vale RD; Garcia KC Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding. Cell 2018, 174 (3), 672–687.e27. 10.1016/j.cell.2018.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (97).Limozin L; Bridge M; Bongrand P; Dushek O; van der Merwe PA; Robert P TCR-pMHC Kinetics under Force in a Cell-Free System Show No Intrinsic Catch Bond, but a Minimal Encounter Duration before Binding. Proc. Natl. Acad. Sci. U. S. A 2019, 116 (34), 16943–16948. 10.1073/pnas.1902141116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (98).Stanford SM; Rapini N; Bottini N Regulation of TCR Signalling by Tyrosine Phosphatases: From Immune Homeostasis to Autoimmunity. Immunology 2012, 137 (1), 1–19. 10.1111/j.1365-2567.2012.03591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (99).Afonin KA; Grabow WW; Walker FM; Bindewald E; Dobrovolskaia MA; Shapiro BA; Jaeger L Design and Self-Assembly of siRNA-Functionalized RNA Nanoparticles for Use in Automated Nanomedicine. Nat. Protoc 2011, 6 (12), 2022–2034. 10.1038/nprot.2011.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (100).Hong E; Halman JR; Shah AB; Khisamutdinov EF; Dobrovolskaia MA; Afonin KA Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles. Nano Lett. 2018, 18 (7), 4309–4321. 10.1021/acs.nanolett.8b01283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (101).Hong E; Halman JR; Shah A; Cedrone E; Truong N; Afonin KA; Dobrovolskaia MA Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells. Molecules 2019, 24 (6). 10.3390/molecules24061094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (102).Halman JR; Satterwhite E; Roark B; Chandler M; Viard M; Ivanina A; Bindewald E; Kasprzak WK; Panigaj M; Bui MN; Lu JS; Miller J; Khisamutdinov EF; Shapiro BA; Dobrovolskaia MA; Afonin KA Functionally-Interdependent Shape-Switching Nanoparticles with Controllable Properties. Nucleic Acids Res. 2017, 45 (4), 2210–2220. 10.1093/nar/gkx008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (103).Afonin KA; Viard M; Tedbury P; Bindewald E; Parlea L; Howington M; Valdman M; Johns-Boehme A; Brainerd C; Freed EO; Shapiro BA The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities. Nano Lett. 2016, 16 (3), 1746–1753. 10.1021/acs.nanolett.5b04676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (104).Afonin KA; Viard M; Kagiampakis I; Case CL; Dobrovolskaia MA; Hofmann J; Vrzak A; Kireeva M; Kasprzak WK; KewalRamani VN; Shapiro BA Triggering of RNA Interference with RNA-RNA, RNA-DNA, and DNA-RNA Nanoparticles. ACS Nano 2015, 9 (1), 251–259. 10.1021/nn504508s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (105).Ke W; Hong E; Saito RF; Rangel MC; Wang J; Viard M; Richardson M; Khisamutdinov EF; Panigaj M; Dokholyan NV; Chammas R; Dobrovolskaia MA; Afonin KA RNA-DNA Fibers and Polygons with Controlled Immunorecognition Activate RNAi, FRET and Transcriptional Regulation of NF-κB in Human Cells. Nucleic Acids Res. 2019, 47 (3), 1350–1361. 10.1093/nar/gky1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (106).Panigaj M; Johnson MB; Ke W; McMillan J; Goncharova EA; Chandler M; Afonin KA Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology. ACS Nano 2019, 13 (11), 12301–12321. 10.1021/acsnano.9b06522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (107).Zadeh JN; Steenberg CD; Bois JS; Wolfe BR; Pierce MB; Khan AR; Dirks RM; Pierce NA NUPACK: Analysis and Design of Nucleic Acid Systems. J. Comput. Chem 2011, 32 (1), 170–173. 10.1002/jcc.21596. [DOI] [PubMed] [Google Scholar]
- (108).Dirks RM; Bois JS; Schaeffer JM; Winfree E; Pierce NA Thermodynamic Analysis of Interacting Nucleic Acid Strands. SIAM Rev. 2007, 49 (1), 65–88. 10.1137/060651100. [DOI] [Google Scholar]
- (109).Tang X; Ali MY; Saif MTA A Novel Technique for Micro-Patterning Proteins and Cells on Polyacrylamide Gels. Soft Matter 2012, 8 (27), 7197–7206. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.